23 results
8-K
EX-2.1
RVTY
Revvity Inc.
15 Mar 23
Entry into a Material Definitive Agreement
6:54pm
8-K
EX-2.1
RVTY
Revvity Inc.
5 Aug 22
Entry into a Material Definitive Agreement
4:22pm
8-K
EX-2.1
RVTY
Revvity Inc.
27 Jul 21
PerkinElmer to Acquire Antibody and Reagent Leader BioLegend
4:33pm
10-K
2017 FY
EX-2.5
RVTY
Revvity Inc.
Annual report
27 Feb 18
12:00am
10-Q
2017 Q2
EX-2.2
RVTY
Revvity Inc.
Quarterly report
8 Aug 17
12:00am
8-K
EX-2.1
r32wrppg333ufbf
22 Dec 16
Entry into a Material Definitive Agreement
12:00am
8-K
EX-2.1
pdjexltygiq0t0de 7k
28 Nov 14
PerkinElmer Enters into Definitive Agreement to Acquire
12:00am
SC 13D
EX-2
hzd4 70rp4
16 Sep 11
CALIPER LIFE SCIENCES / PERKINELMER ownership change
12:00am
8-K
EX-2.1
p21szdjf
13 Sep 11
PerkinElmer to Acquire Caliper Life Sciences for Approximately $600 Million
12:00am
8-K
EX-2.1
obdevyb5vb6uywbfrwws
2 Oct 07
Entry into a Material Definitive Agreement
12:00am
SC TO-C
EX-2.1
hkpkz
2 Oct 07
Information about tender offer
12:00am
SC TO-C
EX-2.1
j2qntq0 j0lw5c
2 Oct 07
Information about tender offer
12:00am
8-K
EX-2.1
32s8liisqp 2z2h
18 Jul 01
Perkinelmer Inc.
12:00am
425
EX-2.1
enb3j3s7 wnbvewzac
18 Jul 01
Business combination disclosure
12:00am
8-K
EX-2.2
ovrnl vbkxg1c4
1 Aug 00
Perkinelmer, Inc.
12:00am
8-K
EX-2.1
vlnnhk8h93
1 Aug 00
Perkinelmer, Inc.
12:00am
8-K
EX-2.1
vh18yf56zu
7 Sep 99
Eg&g, Inc.
12:00am